Group 1: Strategic Investment and Growth - The company has invested in Luoyang Aowite, acquiring an 18% stake, aiming to leverage Aowite's technology and products to penetrate the core components market for robots, fostering new business growth [2][3] - The anticipated sales revenue increase from the investment in Aowite is expected to align with market demand from 2026 to 2028, particularly in high-precision bearings for robotics [2][3] Group 2: Market Performance and Trends - The company has seen a positive trend in orders since Q3 2025, attributed to improved external conditions and strategic capacity planning, which aligns with operational expectations [4][5] - In the North American market, the company has established a strong presence, with revenue from this region accounting for over 80% of total revenue in the first three quarters of 2025, supporting overall performance growth [5] Group 3: Product Innovation and Market Expansion - The company is focusing on the rapidly growing plant lighting market, driven by factors such as policy changes, technological advancements, and increasing demand for local food production [4][5] - The expansion of vertical farming and the legalization of cannabis in several U.S. states have created a robust demand for LED technology in plant lighting, contributing to significant order growth [4][5]

Group 1 - The company signed a framework agreement with the Yangtze River Delta Hart Robot Industry Technology Research Institute, which is a non-binding agreement focused on collaborative research and development in the robotics sector [1][2] - The agreement aims to leverage the company's core advantages in mold development, precision machining, and heat treatment to strategically extend into the core components of robotics [3] - The Hart Research Institute is a high-level research institution established to meet local robotics industry development needs and does not have any affiliation with the company [2] Group 2 - The cooperation agreement was signed on September 3, 2025, in Hangzhou, and does not require board or shareholder approval as it does not involve related transactions or constitute a major asset restructuring [2] - The research collaboration is expected to enhance the company's R&D capabilities and strengthen its core competitiveness, aligning with the long-term development strategy and benefiting all shareholders [3] Group 3 - The framework agreement includes provisions for the management structure of the research collaboration, ensuring that any intellectual property rights obtained during the research will belong to the company [2]